Treatment of tinnitus with acamprosate

Progress in Brain Research

Volumn 166, Issue , 2007, Pages 273-277

  Azevedo, Andréia Aparecida de ^a   Figueiredo, Ricardo Rodrigues ^a,b  

^a OTOSUL Otorrinolaringologia Sul Fluminense   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

acamprosate; NMDA; tinnitus

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ACAMPROSATE; GLUTAMATE RECEPTOR ANTAGONIST; PLACEBO;

AIRWAY OBSTRUCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; EAR; EPIGASTRIC PAIN; HUMAN; NERVOUS SYSTEM; NEUROTRANSMISSION; PRIORITY JOURNAL; REVIEW; TINNITUS;

ALCOHOL DETERRENTS; EXCITATORY AMINO ACID ANTAGONISTS; GABA AGENTS; HUMANS; TAURINE; TINNITUS;

EID: 35348994427     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(07)66025-7     Document Type: Review

References (19)

1. Azevedo A.A., and Figueiredo R.R. Atualização em zumbido. Rev. Bras Otorrinolaring. 70 (2004) 27-40. http://www.otosul.com.br/artigos/medicos/zumbido.pdf Available at http://www.otosul.com.br/artigos/medicos/zumbido.pdf
2. Azevedo A.A., and Figueiredo R.R. Tinnitus treatment with acamprosate: a double-blind study. Rev. Bras. Otorrinolaringol. Engl. Ed. 71 (2005) 618-623
3. Bauer C., and Brozoski T.J. Effect of gabapentin on the sensation and impact of tinnitus. Laryngoscope 116 (2006) 675-681
4. Bonfils P., and Puel J.L. Synapses Cochléaires et Acouphènes. In: Meyer B., et al. (Ed). Acouphènes et hyperacousie Vol. 1 (2001), Société Francaise de Otorhino-laryngologie et Chirurgie de la face e du cou, Paris 275-292
5. Dachour A., and De Witte P. Acamprosate decreases the hypermotility during repeated ethanol withdrawal. Alcohol 18 (1999) 77-81
6. Daoust M., Legrand E., Tran G., Durbin P., Gewiss M., Heidbreder C., and De Witte P. Acamprosate treatment differentially modulates synaptosomal GABA uptake in chronically alcoholized rats. Alcohol. Clin. Exp. Res. 14 (1990) 281
7. Eggermont J. Central tinnitus. Auris Nasus Larynx 30 (2003) 7-12
8. Figueiredo R.R., and Azevedo A.A. Aminoácidos neurotransmissores nas vias auditivas. Revista da Sociedade de ORL do Rio de Janeiro 4 (2004) 49-54. http://www.otosul.com.br Available at http://www.otosul.com.br/aminoacidos_neuro.htm
9. Guitton M.J., Caston J., Ruel J., Johnson R.M., Pujol R., and Puel J.L. Salicylate induces tinnitus through activation of cochlear NMDA receptors. J. Neurosci. 23 (2003) 3944-3952
10. Hastak S.M. Treatment of memory impairment, vertigo and tinnitus in the elderly with piribedil in an Indian general practice setting. J. Indian Med. Assoc. 101 (2003) 500-501
11. Matthiews D.N., Devaud L.L., Fritschy J.M., Siegheart W., and Morrow A.L. Differential regulation of GABA A receptor gene expression by ethanol in the rat hippocampus versus cerebral cortex. J. Neurochem. 70 (1998) 1160-1166
12. A receptor function and gene expression in the central nervous system. Int. Rev. Neurobiol. 38 (1995) 1-41
13. Pierrefiche O., Daoust M., and Naasila M. Biphasic effect of acamprosate on NMDA but not on GABA(A) receptors in spontaneous rhythmic activity from the isolated neonatal rat respiratory network. Neuropharmacology 47 (2004) 35-45
14. Puel J.L., Ruel J., Gervais d'Aldin C., Pujol R., Tribillac F., Ladrech S., and Eybalin M. Excitotoxicity and repair of cochlear synapses after noise-trauma induced hearing loss. Neuroreport 9 (1998) 2109-2114
15. Pujol R., Puel J.L., Gervais d'Aldin C., and Eybalin M. Pathophysiology of the glutamatergic synapses in the cochlea. Acta Otolaryngol. 113 (1993) 330-334
16. Salembier L., De Ridder D., and Van de Heyning P.H. The use of flupirtine in treatment of tinnitus. Acta Otolaryngol. Suppl. 556 (2006) 93-95
17. Vernon J.A., and Meikle B. Masking devices and alprazolam treatment for tinnitus. Otolaryngol. Clin. N. Am. 36 (2003) 307-320
18. Zeise M.L., Kasparov S., Capogna M., and Zieglgansberger W. Acamprosate (calcium acetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex. Possible involvement of excitatory amino acid receptors. Eur. J. Pharmacol. 231 (1993) 47-51
19. Zeise M.L., Kasparow S., Capogna M., and Zieglgansberger W. Calcium diacetylhomotaurinate (Ca-AOTA) decreases the action of excitatory amino acids in the rat neocortex in vitro. Prog. Clin. Biol. Res. 351 (1990) 237-242